Follow-up studies revealed that BCAR4 mRNA levels correlate with tumor aggressiveness in advanced stage BCs and that BCAR4 acts in an ERBB2/3-dependent manner in ZR-75-1 and MCF7 cells [11,10, 9]. This evidence concerns the gene ERBB2 and neoplasm.